Evidence-informed tiering of non-invasive neuromodulation in mental disorders: from core conventional techniques to frontier exploration
10.11886/scjsws20260416001
- VernacularTitle:无创神经调控在精神障碍中的循证分层:从核心常规技术到前沿探索
- Author:
Qiao WU
1
;
Yan LUO
1
;
Qiang ZHANG
1
;
Hongyi SUN
2
;
HuiMin LYU
2
;
Menglei XIAO
2
;
Zhong ZHENG
2
Author Information
1. Sichuan Mental Health Center·The Third Hospital of Mianyang, Mianyang 621000, China
2. Center for Neurological Function Test and Neuromodulation, West China Xiamen Hospital, Sichuan University, Xiamen 361021, China
- Publication Type:Journal Article
- Keywords:
Non-invasive neuromodulation;
Repetitive transcranial magnetic stimulation;
Modified electroconvulsive therapy;
Transcranial direct current stimulation;
Vagus nerve stimulation;
Mental disorders;
Depressive disorder;
Evidence-informed tiering
- From:
Sichuan Mental Health
2026;39(5):385-393
- CountryChina
- Language:Chinese
-
Abstract:
Pharmacotherapy and psychotherapy for mental disorders are hampered by suboptimal efficacy, high relapse rates, and limited applicability across patient populations, making neuromodulation as an important adjunctive treatment option. This evidence-oriented narrative review proposes a working tiering of mainstream non-invasive or minimally invasive neuromodulation techniques based on clinical maturity, systematically delineating their mechanistic underpinnings, clinical evidence profiles, and therapeutic positioning, while further outlining a patient-stratified clinical decision-making pathway. Current evidence indicates that modified electroconvulsive therapy (MECT) and standardized repetitive transcranial magnetic stimulation/intermittent theta-burst stimulation (rTMS/iTBS) constitute the core conventional techniques, with depressive disorder representing the most robustly supported indication. Magnetic seizure therapy (MST), as a promising optimized alternative to MECT, compared with MECT, MST shows a clear advantage in protecting autobiographical memory. Stanford neuromodulation therapy (SNT), an emerging rapid-acting protocol, may provide accelerated treatment options for treatment-resistant depression. Transcranial direct current stimulation (tDCS) has acquired a novel application paradigm following regulatory approval of certain home-use devices. Transcutaneous auricular vagus nerve stimulation (taVNS), external trigeminal nerve stimulation (eTNS), transcranial focused ultrasound (tFUS), and temporal interference stimulation (TIS) are still undergoing indication refinement and evidence accumulation. The central premise of this review is that clinical selection of non-invasive neuromodulation should not be predicated solely on efficacy rankings, but rather on a careful trade-off among evidence maturity, patient urgency, prior treatment history, symptom dimensions, accessibility, and individualization potential.